BACKGROUND: In Alzheimer's disease (AD), levels of N-acetylaspartate (NAA) is diminished and choline (Cho) and myo-inositol (mI) are increased. In cerebrospinal fluid (CSF), tau and phosphoylated tau (p-tau181P) is increased and amyloid-β(1-42) (Aβ42) decreased. OBJECTIVES: 1) To compare metabolites of different 1H-MRS voxels and assess its utility to differentiate AD from controls and to examine the relationship to cognition and to CSF markers. METHODS: 17 healthy controls and 19 AD subjects were studied using 1H-MRS. In the AD cases, additional CSF analysis was obtained. RESULTS: Relative to controls, AD subjects had reduced NAA/Creatine (Cr) levels in hippocampus (42.3% to 26.0%, p < 0.001), posterior cingulate gyrus (10.4% to 0.2%, p = 0.04), and parietal lobe (14.9% to 3.8%, p = 0.002). Further differences of Cho/Cr and mI/Cr in the hippocampus (Cho/Cr: p = 0.04; mI/Cr: p = 0.015) and posterior cingulate (Cho/Cr: p = 0.001; mI/Cr: p = 0.001) were observed. NAA/Cr of the hippocampus yielded the highest sensitivity (94.1%) and specificity (92.3%) to differentiate AD from controls. NAA/Cr was associated with general cognition (hippocampus: R = 0.68, p < 0.001; parietal lobe: R = 0.57, p = 0.001; posterior cingulate: R = 0.50, p = 0.003). Higher hippocampal NAA/Cr was related to higher CSF Aβ42, while lower parietal NAA/Cr was associated with a higher CSF total tau (t-tau) and p-tau181P. Posterior cingulate mI/Cr was related to CSF t-tau and NAA/mI. CONCLUSION: 1H-MRS is an appropriate measure in AD. Measurement at different regions presumably reflects different pathological changes.
BACKGROUND: In Alzheimer's disease (AD), levels of N-acetylaspartate (NAA) is diminished and choline (Cho) and myo-inositol (mI) are increased. In cerebrospinal fluid (CSF), tau and phosphoylated tau (p-tau181P) is increased and amyloid-β(1-42) (Aβ42) decreased. OBJECTIVES: 1) To compare metabolites of different 1H-MRS voxels and assess its utility to differentiate AD from controls and to examine the relationship to cognition and to CSF markers. METHODS: 17 healthy controls and 19 AD subjects were studied using 1H-MRS. In the AD cases, additional CSF analysis was obtained. RESULTS: Relative to controls, AD subjects had reduced NAA/Creatine (Cr) levels in hippocampus (42.3% to 26.0%, p < 0.001), posterior cingulate gyrus (10.4% to 0.2%, p = 0.04), and parietal lobe (14.9% to 3.8%, p = 0.002). Further differences of Cho/Cr and mI/Cr in the hippocampus (Cho/Cr: p = 0.04; mI/Cr: p = 0.015) and posterior cingulate (Cho/Cr: p = 0.001; mI/Cr: p = 0.001) were observed. NAA/Cr of the hippocampus yielded the highest sensitivity (94.1%) and specificity (92.3%) to differentiate AD from controls. NAA/Cr was associated with general cognition (hippocampus: R = 0.68, p < 0.001; parietal lobe: R = 0.57, p = 0.001; posterior cingulate: R = 0.50, p = 0.003). Higher hippocampal NAA/Cr was related to higher CSF Aβ42, while lower parietal NAA/Cr was associated with a higher CSF total tau (t-tau) and p-tau181P. Posterior cingulate mI/Cr was related to CSF t-tau and NAA/mI. CONCLUSION:1H-MRS is an appropriate measure in AD. Measurement at different regions presumably reflects different pathological changes.
Authors: Eva Widerström-Noga; Varan Govind; James P Adcock; Bonnie E Levin; Andrew A Maudsley Journal: J Neurotrauma Date: 2016-01-15 Impact factor: 5.269
Authors: Firat Kara; James M Joers; Dinesh K Deelchand; Young Woo Park; Scott A Przybelski; Timothy G Lesnick; Matthew L Senjem; Burcu Zeydan; David S Knopman; Val J Lowe; Prashanthi Vemuri; Michelle M Mielke; Mary M Machulda; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci Journal: Neurobiol Aging Date: 2022-01-05 Impact factor: 4.673
Authors: Qianyun Chen; Jill Abrigo; Wanting Liu; Elyia Yixun Han; David Ka Wai Yeung; Lin Shi; Lisa Wing Chi Au; Min Deng; Sirong Chen; Eric Yim Lung Leung; Chi Lai Ho; Vincent Chung Tong Mok; Winnie Chiu Wing Chu Journal: Brain Sci Date: 2022-05-31
Authors: Shankar Tumati; Esther M Opmeer; Jan-Bernard C Marsman; Sander Martens; Fransje E Reesink; Peter P De Deyn; André Aleman Journal: Front Aging Neurosci Date: 2018-04-13 Impact factor: 5.750
Authors: Satya V V N Kothapalli; Tammie L Benzinger; Andrew J Aschenbrenner; Richard J Perrin; Charles F Hildebolt; Manu S Goyal; Anne M Fagan; Marcus E Raichle; John C Morris; Dmitriy A Yablonskiy Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.472